David A McLain MD FACP, MACR, FRCP (He/Him)

McLain Medical Associates, P.C., Symposium Director, Congress of Clinical Rheumatology, Destin , FL and Huntington Beach, CA

Join to view full profile

2229 Cahaba Valley DRBirmingham, AL 35242
Phone+1 205-991-8996
Fax+1 205-991-8997

Dr. McLain is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McLain's full profile Already have an account?

Summary

David McLain, a Birmingham, AL-based Rheumatologist, earned his MD from Tulane U. and completed his residency/fellowship at Wash. U./Barnes. He is Symposium Dir. for the Congress of Clinical Rheumatology, Exec. Dir. of the AL Soc. for Rheumatic Dis. , and at McLain Med Assoc. He has research work on low-dose naltrexone for chronic pain. Dr. McLain is a Fellow of the Royal Coll. of Physicians.

Clinical Expertise

Principal Investigator, Rheumatoid arthritis, Systemic lupus erythematosus, Sjogren's syndrome, Psoriatic arthritis, Gout, Fibromyalgia, Hashimoto's thyroiditis, Ankylosing spondylitis, Osteoporosis, Osteoarthritis, Reactive arthritis, Systemic Scleroderma, Arthritis, Submersion injury

Education & Training

International Society for Clinical DensitometryC.C.D, Clinical, Densitometry, 2002 - 2002
Washington University/B-JH/SLCH ConsortiumFellowship, Rheumatology, 1977 - 1979
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1977
Ochsner Clinic FoundationInternship, Internal Medicine, 1974 - 1975
Tulane University School of MedicineClass of 1974

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

AL State Medical License 1981 - 2026
LA State Medical License 1974 - 1977
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Best Rheumatology Practice Guide to Alabama’s Best of Alabama 2025, 2025
Fellow Royal College of Physicians (London, England), 2023
Master (MACR) American College of Rheumatology

Clinical Trials

Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
COMPLETED
NA

Publications & Presentations

PubMed

5 citations
Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain.
Roy D Altman, Robert W Ike, Max I Hamburger, David A McLain, Michael J Daley
The Journal of Rheumatology. 2022-08-01
187 citations
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Jarred Younger, Luke Parkitny, David A. McLain
Clinical Rheumatology. 2014-02-15
4 citations
Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA
Surrey M. Walton, Glen T. Schumock, David A. McLain
Current Medical Research and Opinion. 2010-08-15

Journal Articles

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Jarred Younger, Luke Parkitny, David McLain, Clinical Rheumatology, 2/2014
Medicine does not exist in a Vacuum.
McLain, DA, MASA Review, 1: 23-25
Current trends in the Diagnosis and Treatment of Chronic Neuromuscular Pain Syndromes: Myofascial Pain Syndrome, Chronic Tension-Type Headache, and Fibromyalgia.
Jay, GW, Krusz, JC, Longmire, DR, McLain, DA, The American Academy of Pain Management

Books/Book Chapters

Pain Management Secrets
Chapter: Fibromyalgia and Myofascial Pain Syndrome
David McLain, MDEditors: Argoff MD, Charles E., Dubin MD MS, Andrew, Pilitsis MD PhD, Julie.ElsevierEdition 4th,2018
Diseases of the Thyroid, Parathyroid, and Adrenal Glands
McLain, DA, McLain, PF, Lindsey, ES, and Ryan, RFEditors: Ryan, RF.Tulane University Press, New OrleansEdition 1st,1975
Chapter: Lessons from fibromyalgia: abnormal pain sensitivity in knee osteoarthritis
Bradley LA, Kersh BC, DeBerry JJ, Deutsch G, Alarcon GA, McLain DAEditors: Derek J. Chadwick, Jamie Goode.Novartis Found Symp. 2004;260:258-70; discussion 270-9

Abstracts/Posters

Colchicine and Pseudogout
McLain, DA, Spilberg, l, Berney, S. Simchowitz, L, Arthritis and Rheumatism, 23: 718
An HLA Public Antigen is More Common than HLA B27 in Patients with Ankylosing Spondylitis.
McLain, DA, Luehrman, LK, Rodey, GE, Schwartz, BD, Arthritis and Rheumatism, 23: 718
HLA Public Antigen is More Common than HLA B27 in Patients with Ankylosing Spondylitisn, in Preud'Homme and Hawken.
McLain, DA, Luehrman, LK, Rodey, GE, Schwartz, BD, 4th International Congress of Immunology, Paris

Authored Content

A Vast Array of Eye-Opening Studies Were Featured at ACR 2022November 2022
Commentary on Manzi Lupus articleJuly 2019
Commentary on Filgotinib in RA articleJuly 2019

Press Mentions

Exploration of RA-ILD Biomarkers Reveals ‘New Opportunities’ for Screening, TreatmentApril 30th, 2025
Quick Facts About Fibromyalgia and Related DiseasesJanuary 14th, 2017

Research History

Principal Investigator, Achieve Clinical Research, LLC--rheumatoid arthritis, osteoporosis, osteoarthritis, lupus, psoriatic arthritis, fibromyalgia2008 - 2014